Boston Scientific Closes Symetis Acquisition
Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease
MARLBOROUGH, Mass., May 16, 2017 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: B... Devices, Interventional, Cardiology, Mergers & Acquisitions Boston Scientific, Symetis SA, transcatheter aortic valve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Heart Disease | Marketing | Mergers and Aquisitions | Pharmaceuticals